P

PCRX

PharmaCorp Rx

0.48

-0.01-2.04%
Closed14:16 06/27 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
Total Assets

35.21M

2.32M

2.73M

1.00M

Total Current Assets

14.57M

2.32M

2.73M

1.00M

Total Non Current Assets

20.63M

0

0

0

Total Liabilities

4.64M

46.19K

16.47K

26.34K

Total Current Liabilities

1.70M

46.19K

16.47K

26.34K

Total Non Current Liabilities

2.95M

0

0

0

Total Equity

30.57M

2.27M

2.72M

974.18K

Total Stockholders Equity

30.34M

2.27M

2.72M

974.18K

Minority Interest

222.48K

--

--

--

Total Liabilities & Shareholders Equity

35.21M

2.32M

2.73M

1.00M

Total Common Shares Outstanding

117.30M

40.28M

40.00M

40.00M

Total Preferred Shares Outstanding

--

--

--

--